GlaxoSmithKline is moving forward with a new plant in Scotland to expand API production for its COPD drug Ventolin, which has been one of the bright spots in its respiratory business. The U.K.-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results